Latest Headlines

  1. Collaborative Drug Discovery Partners With Lilly TuneLab To Make Lilly AI/ML Models Available In CDD Vault 5/20/2026

    Collaborative Drug Discovery (CDD), the leading provider of data management solutions for the pharmaceutical and biotechnology industries, today announced an agreement with Eli Lilly and Company (Lilly) to integrate Lilly TuneLab, a collaborative AI/ML drug discovery platform, into CDD Vault.

  2. Araceli Biosciences Launches Endeavor® Live Cell For Ultra-High-Throughput Kinetic Imaging In AI-Driven Drug Discovery 5/20/2026

    Araceli Biosciences today announced the launch of Endeavor® Live Cell, extending the company's ultra-high-throughput imaging platform into dynamic biology at screening scale.

  3. Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery 5/19/2026

    Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free Protein Synthesis Kit (Cat#: CFKIT02), a cutting-edge solution designed to supercharge artificial intelligence (AI)-driven high-throughput screening pipelines for antibody drug discovery.

  4. FSU Chemists Use Sea Sponge Bacteria To Create New Molecules For Drug Discovery 5/19/2026

    Florida State University chemists have synthesized new molecules derived from bacteria found in a Pacific Ocean sea sponge, a breakthrough for the future of drug development, particularly for rare forms of cancer.

  5. Rancho BioSciences Launches OmicsHQ™: A Comprehensive, Curated, Multi-Omics Data Platform Built To Accelerate Drug Discovery 5/19/2026

    Today Rancho BioSciences, the premier tech-enabled data science partner for biopharma, announced the launch of OmicsHQTM, a unified catalog of expertly curated, standardized multi-omics datasets designed for immediate use in research, drug discovery, and AI/ML model development. The company is launching the product at BioIT World Conference & Expo, May 19, 2026, Boston, MA.

  6. Genedata Introduces AI-Native CMC Platform To Accelerate Drug Development And Manufacturing 5/19/2026

    Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharma R&D, today announced the launch of Genedata Vico™, an AI–native solution to accelerate CMC processes by enabling data-driven experimentation, process monitoring, and predictive risk assessment — helping organizations strengthen regulatory readiness and reduce development delays.

  7. QIAGEN To Advance AI-Driven Drug Discovery With Graph-Based AI And Curated Bioinformatics Knowledge With NVIDIA 5/19/2026

    QIAGEN announced at the 2026 BIO-IT World Conference & Expo in Boston that the QIAGEN Digital Insights bioinformatics business and its curated knowledge bases and bioinformatics expertise will be integrating NVIDIA accelerated computing and the NVIDIA BioNeMo platform to help researchers use AI more effectively in drug discovery.

  8. U.S. FDA Accepts Viatris New Drug Application For Fast-Acting Meloxicam For The Treatment Of Moderate-To-Severe Acute Pain 5/18/2026

    Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for MR-107A-02 (fast-acting meloxicam), a non-opioid, for the treatment of moderate-to-severe acute pain.

  9. Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development 5/18/2026

    Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), has entered a manufacturing and supply arrangement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited (ABN 70 009 109 755) (ASX:BOT) ("Botanix"), a commercial dermatology company.

  10. The Solubility Company And Persist AI Unveil Strategic Partnership To Enable Microgram-Level Formulation Development And Bridge The Data Gap In AI-Driven Drug Formulation 5/13/2026

    The Solubility Company, the pioneer of ultra-low sample solubility measurement, and Persist AI, an AI-Driven automated Pharma Formulation Cloud Lab, today announced a strategic collaboration to launch the first fully automated SPA® platform (single particle analysis).